Assessment of stigma in patients with cystic fibrosis

BMC Pulmonary Medicine

Louise Balfour¹  William Cameron¹  Giorgio Tasca¹  Shawn Aaron²  Ena Gaudet³  Rojiemiahd Edjoc⁴  Crystal Holly¹  Michael Armstrong⁴  Smita Pakhale² 

[1] The University of Ottawa, 451 Smyth Road, K1H 8 M5 Ottawa, Ontario, Canada;Division of Respiratory Medicine, The Ottawa Hospital, 501 Smyth Road, Ottawa, Ontario K1H 8 L6, Canada;The Ottawa Hospital, 501 Smyth Road, K1H 8 M5 Ottawa, Ontario, Canada;Ottawa Hospital Research Institute, 501 Smyth Road, K1H 8 M5 Ottawa, Ontario, Canada

关键词: Focus group;    Validation;    Treatment Adherence;    Psychometric;   

Others  :  862968
DOI  :  10.1186/1471-2466-14-76

 received in 2014-01-27, accepted in 2014-04-15,  发布年份 2014

【 摘 要 】

Background

Research that explores stigma in Cystic Fibrosis (CF) is limited. Productive cough, repeated lung infections, and periods of serious illness requiring hospitalizations are among common symptoms of CF. These symptoms may cause a negative perception by others. We developed a CF-specific Stigma Scale and tested its psychometric properties.

Methods

We conducted a focus group with 11 participants including adult patients with CF (n = 5) and their informal caregivers (n = 6). The thematic content of the focus group was analyzed to find key themes. We developed a CF-specific Stigma Scale and assessed its psychometric properties in a 3-month prospective cohort study of adult CF outpatients (n = 45).

Results

Stigma emerged as consistent concern for people living and caring for those with CF, affecting both patients’ lives and health through the focus group. Using the newly developed CF Stigma scale, the mean baseline score was 16.6 (SD = 4.5, Range = 10-25). The CF Stigma Scale demonstrated robust psychometric properties: 1) Internal consistency: α = 0.79; 2) Mean inter-item correlation: 0.30 with good test-retest reliability; 3) Convergent validity: Positive associations with depression, severity of CF symptoms and anxiety; negative associations with validated quality of life scores were observed.

Conclusions

Stigma is measurable and significantly impacts the lives of CF patients. Further research should investigate the role of stigma in patients living with CF.

【 授权许可】

   
2014 Pakhale et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]National Institutes of Health: Cystic Fibrosis, Facts About. Bethesda, MD: National Heart, Lung and Blood Institute; 1995:95-3650.
• [2]Ferrin M, Cianci K, Finnerty M, McDonald G, Smith T, Thrasher S: Cystic Fibrosis in the workplace. The Questions, the Needs, The Solutions. Bethesda, MD: Cystic Fibrosis Foundation; 2003.
• [3]Cystic Fibrosis Canada: Insurance with people with Cystic Fibrosis. Toronto, ON, Canada; 2013.
• [4]Ernst MM, Johnson MC, Stark LJ: Developmental and psychosocial issues in CF. Child Adolesc Psychiatr Clin N Am 2010, 19:263.
• [5]Bok C: Relationships of health behaviours with stigma and quality of life among adolscent and young adults with Cystic Fibrosis. OH: Ohio State University; 2011.
• [6]Taylor LA, Wallander JL, Anderson D, Beasley P, Brown RT: Improving health care utilization, improving chronic disease utilization, health status, and adjustment in adolescents and young adults with cystic fibrosis: a preliminary report. J Clin Psychol Med S 2003, 10:9-16.
• [7]Havermans T, Colpaert K, Dupont LJ: Quality of life in patients with cystic fibrosis: association with anxiety and depression. J Cyst Fibros 2008, 7:581-584.
• [8]Berge JM, Patterson J: Cystic fibrosis and the family: a review and critique of the literature. Fam Syst Health 2004, 22:74-100.
• [9]Steinhausen HC, Schindler HP: Psychosocial adaptation in children and adolescents with cystic fibrosis. J Dev Behav Pediatr 1981, 2:74-77.
• [10]Cataldo JK, Slaughter R, Jahan TM, Pongqun VL, Hwang WJ: Measuring stigma in people with lung cancer: psychometric testing of the Cataldo lung cancer stigma scale. Oncol Nurs Forum 2011, 38:E46-E54.
• [11]Holzemer WL, Human S, Arudo J, Rosa ME, Hamilton MJ, Corless I, Robinson L, Nicholas PK, Wantland DJ, Moezzi S, Willard S, Kirksey K, Portillo C, Sefcik E, Rivero-endez M, Maryland M: Exploring HIV stigma and quality of life for persons living with HIV infection. J Assoc Nurses AIDS Care 2009, 20:161-168.
• [12]Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS: Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS 2006, 20:359-368.
• [13]Parker R, Aggleton P: HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med 2010, 137:642-650.
• [14]Pizzignacco TM, de Mello DF, de Lima RA: Stigma and cystic fibrosis. Rev Lat Am Enfermagem 2010, 18:139-142.
• [15]Braun V, Clarke V: Using thematic analysis in psychology. Qual Res Psychol 2006, 3:77-101.
• [16]Cystic Fibrosis Canada: Canadian Cystic Fibrosis Patient Data Registry Report. Toronto, ON, Canada; 2010.
• [17]Berger BE, Ferrans CE, Lashley FR: Psychometric assessment of the HIV stigma scale. Research in Nursing and Health. Res Nurse Health 2001, 24:518-529.
• [18]Wright K, Naar-King S, Lam P, Templin T, Frey M: Stigma scale revised: reliability and validity of a brief measure of stigma for HIV + youth. J Adolesc Health 2007, 40:96-98.
• [19]Ware JKM&KSD: 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996, 34:220-233.
• [20]Gee L, Abbott J, Conway SP, Etherington C, Webb AK: Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2006, 55:946-954.
• [21]Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas 1997, 3:385-401.
• [22]Spitzer RL, Kroenke K, Williams JB, Lowe B: A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006, 166:1092.
• [23]Tabachnick BG, Fidell LS: Using multivariate statistics. 5th edition. Boston: U.S.A: Pearson Education; 2001.
• [24]Cronbach LJ: Coefficient and the internal structure of tests. Psychometrika 1951, 16:297-334.
• [25]Preacher KJ, Hayes AF: SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Meth Instrum Comput 2004, 36:717-731.
• [26]Logie C, James L, Wangari T, Loutfy M: Associations between HIV-related stigma, racial discrimination, gender discrimination, and depression among HIV-positive African, Caribbean, and black women in Ontario, Canada. AIDS Patient Care STDS 2013, 27:114-122.
• [27]Quittner AL, Espelage DL, Ievers-Landis C, Drotar D: Measuring adherence to medical treatments in childhood chronic illness: considering multiple methods and sources of information. J Clin Psychol Med S 2000, 7:41-54.